Bioptimus
8 known investors
Bioptimus builds multimodal foundation models for biology, including H-Optimus for histology and M-Optimus which integrates pathology, spatial transcriptomics, and genomics, to extract clinically relevant insights from patient data. Its models serve pharmaceutical companies, researchers, and clinical practices for applications such as drug target prediction, patient stratification in trials, and biomarker discovery.